Biocartis Group N.V.
BIOGF · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.04 | -0.27 | 1.26 | 0.00 |
| FCF Yield | -125.38% | -30.51% | -20.29% | -25.23% |
| EV / EBITDA | -3.07 | -6.27 | -5.47 | -4.52 |
| Quality | ||||
| ROIC | -50.72% | -51.75% | -24.87% | -22.07% |
| Gross Margin | 48.16% | 29.72% | 39.06% | 43.04% |
| Cash Conversion Ratio | 0.69 | 0.92 | 0.62 | 0.85 |
| Growth | ||||
| Revenue 3-Year CAGR | 10.05% | 8.83% | 3,506,770.86% | 3,345,397.78% |
| Free Cash Flow Growth | 32.65% | -64.28% | 25.51% | 0.00% |
| Safety | ||||
| Net Debt / EBITDA | -2.22 | -1.94 | -0.65 | 0.23 |
| Interest Coverage | -4.21 | -6.72 | -4.60 | -7.83 |
| Efficiency | ||||
| Inventory Turnover | 1.58 | 2.11 | 1.67 | 1.51 |
| Cash Conversion Cycle | 201.11 | 175.70 | 151.34 | 200.87 |